These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20536595)

  • 61. Diagnosis of mitochondrial diseases: clinical and histological study of sixty patients with ragged red fibers.
    Challa S; Kanikannan MA; Murthy JM; Bhoompally VR; Surath M
    Neurol India; 2004 Sep; 52(3):353-8. PubMed ID: 15472426
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.
    Schleinitz N; Cognet C; Guia S; Laugier-Anfossi F; Baratin M; Pouget J; Pelissier JF; Harle JR; Vivier E; Figarella-Branger D
    Arthritis Rheum; 2008 Oct; 58(10):3216-23. PubMed ID: 18821690
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inflammatory myopathies: narrowing the differential diagnosis.
    Rendt K
    Cleve Clin J Med; 2001 Jun; 68(6):505, 509-14, 517-9. PubMed ID: 11405612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional and isokinetic assessment of muscle strength in patients with idiopathic inflammatory myopathies.
    Neri R; Mosca M; Stampacchia G; Vesprini E; Tavoni A; d'Ascanio A; Bombardieri S
    Autoimmunity; 2006 May; 39(3):255-9. PubMed ID: 16769660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytokines in idiopathic inflammatory myopathies.
    Salomonsson S; Lundberg IE
    Autoimmunity; 2006 May; 39(3):177-90. PubMed ID: 16769651
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies.
    Lim J; Eftimov F; Raaphorst J; Aronica E; van der Kooi AJ
    Eur J Neurol; 2019 Dec; 26(12):1494-1496. PubMed ID: 31220379
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MRI and muscle imaging for idiopathic inflammatory myopathies.
    Malartre S; Bachasson D; Mercy G; Sarkis E; Anquetil C; Benveniste O; Allenbach Y
    Brain Pathol; 2021 May; 31(3):e12954. PubMed ID: 34043260
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Epidemiology, etiology and classification].
    Irazoque-Palazuelos F; Barragán-Navarro Y
    Reumatol Clin; 2009 Nov; 5 Suppl 3():2-5. PubMed ID: 21794659
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis.
    Limaye V; Hakendorf P; Woodman RJ; Blumbergs P; Roberts-Thomson P
    Intern Med J; 2012 Feb; 42(2):191-8. PubMed ID: 21118413
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study.
    Štorkánová H; Oreská S; Špiritović M; Heřmánková B; Bubová K; Kryštůfková O; Mann H; Komarc M; Slabý K; Pavelka K; Šenolt L; Zámečník J; Vencovský J; Tomčík M
    Front Immunol; 2022; 13():811045. PubMed ID: 35154129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Health-related quality of life and work impairment in idiopathic inflammatory myopathies in South Australia.
    Xu A; Sun C; Metcalf R; Limaye V
    Int J Rheum Dis; 2021 Jun; 24(6):809-814. PubMed ID: 33881230
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Percutaneous needle muscle biopsy in the evaluation of patients with suspected inflammatory myopathy.
    Campellone JV; Lacomis D; Giuliani MJ; Oddis CV
    Arthritis Rheum; 1997 Oct; 40(10):1886-91. PubMed ID: 9336426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The incidence of idiopathic inflammatory myopathies in the adult Slovenian population.
    Ostrovršnik J; Hočevar A; Rotar Ž; Krošel M; Čučnik S; Jurčić V; Tomšič M
    Clin Rheumatol; 2019 Feb; 38(2):279-283. PubMed ID: 30073460
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Familial autoimmunity in patients with idiopathic inflammatory myopathies.
    Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist ME
    J Intern Med; 2023 Feb; 293(2):200-211. PubMed ID: 36165332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Idiopathic inflammatory myopathies: one year in review 2022.
    Dourado E; Bottazzi F; Cardelli C; Conticini E; Schmidt J; Cavagna L; Barsotti S
    Clin Exp Rheumatol; 2023 Mar; 41(2):199-213. PubMed ID: 36826800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selected aspects of the current management of myositis.
    Lilleker J; Murphy S; Cooper R
    Ther Adv Musculoskelet Dis; 2016 Aug; 8(4):136-44. PubMed ID: 27493692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inflammatory myopathies in children.
    Compeyrot-Lacassagne S; Feldman BM
    Pediatr Clin North Am; 2005 Apr; 52(2):493-520, vi-vii. PubMed ID: 15820377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. One year in review 2016: idiopathic inflammatory myopathies.
    Orlandi M; Barsotti S; Cioffi E; Tenti S; Toscano C; Baldini C; Neri R
    Clin Exp Rheumatol; 2016; 34(6):966-974. PubMed ID: 27991411
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical presentation of the idiopathic inflammatory myopathies.
    Yazici Y; Kagen LJ
    Rheum Dis Clin North Am; 2002 Nov; 28(4):823-32. PubMed ID: 12506774
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dermatomyositis: a contemporary review for oral health care providers.
    Tanaka TI; Geist SM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e1-8. PubMed ID: 23036799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.